<DOC>
	<DOCNO>NCT01723683</DOCNO>
	<brief_summary>There reduce incidence pneumothorax , PIE combine outcome death BPD since development Surfactant therapy . A policy intubation surfactant administration mechanical ventilation become standard therapy infant high risk RDS . However , initial stabilization CPAP , necessary , give rescue surfactant therapy remain standard therapy preterm infant . Evidence reveals similar result regard mortality neonatal morbidity two strategy . The investigator intend develop method minimally invasive surfactant therapy follow early CPAP ( MISTCPAP ) preterm Infants high risk RDS improve outcomes reduce incidence BPD .</brief_summary>
	<brief_title>Minimally Invasive Surfactant Therapy Followed CPAP ( MISTCPAP ) Preterm Infants With RDS</brief_title>
	<detailed_description>Background . Reducing incidence pneumothorax , PIE combine outcome death BPD achieve since development Surfactant therapy . It also approve initial stabilization CPAP rescue surfactant administration , necessary , result less ventilator day trend towards low risk CLD . However , number infant start CPAP ultimately require intubation administration surfactant within first 72 hour remain high preterm infant . Usually CPAP failure due unremitting RDS require surfactant therapy . Outcomes infant CPAP whole could improve subgroup infant show early sign surfactant deficiency receive early dose surfactant . Objective . This study intents develop method minimally invasive surfactant therapy follow early CPAP ( MISTCPAP ) preterm Infants high risk RDS improve outcomes reduce incidence BPD . We propose prospective randomize control trial compare MISTCPAP technique INSURE technique surfactant administration , involve intubation solely purpose surfactant administration follow immediate extubation CPAP . The outcome trial could declare effect intubation positive pressure ventilation effectiveness surfactant therapy . Methods . This study approve Institutional Review Board ( IRB ) CMUH.Very preterm infant ( GA &lt; 32 wks ) admit NICU CMUH 1 February 2012 31 January 2013 enrol study . Infants stay hospital le 10 day admit 24 hour birth major congenital malformation exclude . Eligible infant randomize allocate 2 group birth use simple randomization seal nontransparent envelope parental consent obtain . MISTCPAP group : The 16Gz 13 cm length Angio-Cath use mark point comparable level infant 's lip ( weight Kg + 6 cm routine ETT intubation ) give operator mark secure Angio-Cath procedure prevent go far trachea . The infant kept supine upper part body raise 30 degree , oro-gastric ( OG ) tube insert , infant receive sedation . The CPAP may remove transiently oxygen cannula O2 flow face may give indicated saturation monitoring procedure . After insert Angio-Cath , laryngoscope remove stabilize Catheter 2 finger . Surfactant ( Survanta© , Abbott , USA ) 100 mg/kgBW , equivalent 4 ml/kgBW per dose drawn 10 ml syringe instillated via Angio-Cath . Prior begin clinical trial , every neonatal fellow train familiar procedure supervision PI ( BH Su ) , average duration procedure achieve range 1-3 minute . All vital sign , include Heart Rate , Respiratory Rate , Oxygen Saturation ( SpO2 ) FiO2 ( Fraction Inspired Oxygen ) requirement monitor . After procedure surfactant instillation , Angio-Cath remove nCPAP resume CPAP level keep constant 5 cmH2O . The oro-gastric ( OG ) tube draw check surfactant instillated reflexed back stomach . As INSURE group , procedure accord conventional surfactant treatment involve intubation , surfactant ( Survanta© , Abbott , USA ) 100 mg/kgBW , equivalent 4 ml/kgBW divide 4 liquor inject 4 position follow amubagging extubation CPAP . The clinical course NICU study infant , include intraventricular hemorrhage ( IVH ) , retinopathy prematurity ( ROP ) , duration ventilation , duration hospital stay , infection , duration oxygen requirement BPD record .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>1 . Very preterm infant ( GA &lt; 32 wks ) admit NICU CMUH 1 February 2012 31 January 2013 enrol study 2 . Less 36 hour age 3 . Clinical sign RDS requirement FiO2 ≥ 0.35 1 . Previous Intubation imminent need IMV e.g . apnea , severe bradycardia deterioration attribute RDS , e.g . shock 2 . Major congenital malformation 3 . No parental consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Hours</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Preterm infant</keyword>
	<keyword>RDS</keyword>
	<keyword>Surfactant</keyword>
	<keyword>MISTCPAP</keyword>
	<keyword>CPAP</keyword>
</DOC>